Last reviewed · How we verify
Emodin
At a glance
| Generic name | Emodin |
|---|---|
| Also known as | Frangula emodin,Frangulic acid |
| Sponsor | Zhi-Hong Liu, M.D. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NA)
- BeaRberry in the Treatment of Acute UncoMplIcated Cystitis (BRUMI)- Protocol of a Multicentre, Randomized Double-Blind Clinical Trial (NA)
- The Effect of Emotional Freedom Technique Applied to Postmenopausal Women on Sleep and Quality of Life: A Randomized Controlled Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Emodin CI brief — competitive landscape report
- Emodin updates RSS · CI watch RSS
- Zhi-Hong Liu, M.D. portfolio CI